Newpath Management logo

Newpath Management

North America, Massachusetts, United States, Boston

Description

Newpath Partners is a life science venture firm dedicated to excellent science and to forming partnerships.

Investor Profile

Newpath Management has made 19 investments, with 5 in the past 12 months and 47% as lead.

Stage Focus

  • Series A (42%)
  • Series B (26%)
  • Series Unknown (16%)
  • Seed (11%)
  • Series C (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Therapeutics
  • Life Science
  • Pharmaceutical
  • Biopharma
  • Genetics
  • Alternative Medicine
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Newpath Management frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 8
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Casdin Capital
North America, New York, United States, New York
Co-Investments: 5
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 4
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3
Invus
North America, New York, United States, New York
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 11

What are some of recent deals done by Newpath Management?

nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
Metsera

New York, New York, United States

Metsera is a biopharmaceutical company that develops medicines for obesity and metabolic diseases.

BiopharmaHealth CareMedicalPharmaceutical
Series BNov 13, 2024
Amount Raised: $215,000,000
Leal Therapeutics

Worcester, Massachusetts, United States

Leal Therapeutics develops novel therapeutics for patients.

MedicalTherapeutics
Series UnknownOct 30, 2024
Amount Raised: $6,000,000
Autobahn Therapeutics

San Diego, California, United States

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CJul 24, 2024
Amount Raised: $100,000,000
Metsera

New York, New York, United States

Metsera operates as a clinical-stage biopharmaceutical company.

BiopharmaHealth CareMedical
Series AApr 18, 2024
Amount Raised: $290,000,000
Nvelop Therapeutics

Cambridge, Massachusetts, United States

Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.

BiotechnologyGeneticsMedical
SeedSep 25, 2023
Amount Raised: $100,000,000
Magnet Biomedicine

Cambridge, Massachusetts, United States

Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.

BiotechnologyMedicalPharmaceutical
Series ASep 19, 2023
Amount Raised: $50,000,000
Myeloid Therapeutics

Cambridge, Massachusetts, United States

Myeloid Therapeutics is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.

BiotechnologyLife ScienceTherapeutics
Series AMay 18, 2023
Amount Raised: $73,000,000
Orbital Therapeutics

Cambridge, Massachusetts, United States

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Alternative MedicineBiotechnologyLife ScienceTherapeutics
Series AApr 26, 2023
Amount Raised: $270,000,000
Chroma Medicine

Cambridge, Massachusetts, United States

Chroma Medicine is a new genomic medicine company working on epigenetic editing.

BiotechnologyMedicalTherapeutics
Series BMar 1, 2023
Amount Raised: $135,000,000